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Abstract
Background: Diagnosis of neuromuscular diseases in primary care is often challenging. Rare diseases such as
Pompe disease are easily overlooked by the general practitioner. We therefore aimed to develop a diagnostic
support tool using patient-oriented questions and combined data mining algorithms recognizing answer patterns
in individuals with selected neuromuscular diseases. A multicenter prospective study for the proof of concept was
conducted thereafter.
Methods: First, 16 interviews with patients were conducted focusing on their pre-diagnostic observations and
experiences. From these interviews, we developed a questionnaire with 46 items. Then, patients with diagnosed
neuromuscular diseases as well as patients without such a disease answered the questionnaire to establish a
database for data mining. For proof of concept, initially only six diagnoses were chosen (myotonic dystrophy and
myotonia (MdMy), Pompe disease (MP), amyotrophic lateral sclerosis (ALS), polyneuropathy (PNP), spinal muscular
atrophy (SMA), other neuromuscular diseases, and no neuromuscular disease (NND). A prospective study was
performed to validate the automated malleable system, which included six different classification methods combined
in a fusion algorithm proposing a final diagnosis. Finally, new diagnoses were incorporated into the system.
Results: In total, questionnaires from 210 individuals were used to train the system. 89.5 % correct diagnoses were
achieved during cross-validation. The sensitivity of the system was 93–97 % for individuals with MP, with MdMy and
without neuromuscular diseases, but only 69 % in SMA and 81 % in ALS patients. In the prospective trial, 57/64 (89 %)
diagnoses were predicted correctly by the computerized system. All questions, or rather all answers, increased the
diagnostic accuracy of the system, with the best results reached by the fusion of different classifier methods. Receiver
operating curve (ROC) and p-value analyses confirmed the results.
Conclusion: A questionnaire-based diagnostic support tool using data mining methods exhibited good results in
predicting selected neuromuscular diseases. Due to the variety of neuromuscular diseases, additional studies are
required to measure beneficial effects in the clinical setting.
Keywords: Diagnostic support, Rare neuromuscular diseases, Data mining, Questionnaire
* Correspondence: Grigull.lorenz@mh-hannover.de
1Department of Pediatric Hematology and Oncology, Hannover Medical
School, Carl-Neuberg Str. 1, D-30623 Hannover, Germany
Full list of author information is available at the end of the article
© 2016 Grigull et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Grigull et al. BMC Medical Informatics and Decision Making  (2016) 16:31 
DOI 10.1186/s12911-016-0268-5
Background
Patients with late-onset Pompe disease [glycogen storage
disease II, acid-maltase deficiency (MP)], motor neuron dis-
ease, muscular dystrophy, or other neuromuscular diseases
frequently experience diagnostic delay [1–4]. The rarity of
these diseases together with clinical variability, atypical pre-
sentations, or lack of time for a thorough examination and
medical history taking contribute to the delay in diagnosis.
In patients with late-onset MP, the diagnostic latency can
be more than 20 years [5]. For amyotrophic lateral sclerosis
(ALS) patients, the median time from onset of first symp-
tom to diagnosis has been reported to be 11 months [6, 7].
The past medical history offers important clues for
diagnosing neuromuscular diseases. Indeed, medical his-
tory taking is one of the oldest arts in medicine, but
introduction of new reimbursement systems has resulted
in less time for communication between physicians and
patients and relatives [8]. One goal of this study was
therefore to integrate the past medical history into a
diagnostic tool and to combine it with modern statistical
technologies. In addition, to incorporating the patient’s
point of view, we explored the past medical history using
questions that were created systematically following in-
terviews focusing on the pre-diagnostic time period.
Likewise, the practical experiences of the patient should
be closely integrated into the diagnostic process.
We aimed to develop a computerized diagnostic support
tool for earlier identification of neuromuscular diseases. In
our previous work, we exploited useful scenarios for
medical diagnostic support and generated a novel diag-
nostic support tool for the pediatric emergency depart-
ment [9]. This ‘emergency tool’ used 14 clinical (e.g. body
temperature, blood pressure, pain) and 12 laboratory pa-
rameters (e.g. blood count, CRP level, blood-gas analysis)
to produce a possible diagnosis. In this study, the system
had a diagnostic accuracy between 81 and 97 % for 17
diagnoses such as meningitis, appendicitis, and pneumo-
nia. Although successful, this tool excluded important
parts of the past medical history. Therefore, we intended
to develop a tool focusing on patients’ perceptions
and experiences. In the current project for diagnostic
support for individuals with selected neuromuscular
diseases; we incorporated patients’ pre-diagnostic experi-
ences and observations to collect answer patterns using
questionnaires. Data mining methods then proved to be a
reliable tool for answer pattern recognition. This novel
tool could serve as diagnostic support for general practi-
tioners (GP) to shorten the diagnostic time in patients
with uncommon neuromuscular diseases.
Methods
Study design and interviews
In this multicenter prospective pilot study, we tested
whether the patient experience explored via a questionnaire
could provide diagnostic support for selected rare neuro-
muscular diseases characterized by long diagnostic latency.
First, to gain insight into the patient’s viewpoint during pre-
diagnostic phase, interviews with 16 patients with different
neuromuscular diseases [MP, ALS, and muscular dystrophy
(MD)] were performed across Germany between Septem-
ber 2011 and February 2012 by two authors (US and LG).
These semi-structured (narrative) interviews lasted between
45 min and 2.5 h and started with the same initial question
(“Please tell us everything that comes to mind before your
diagnosis was established. Relay to us everything you con-
sider to be of any importance: your observations and expe-
riences that you would like to share”). At the conclusion of
the patient’s narrative, the interviewer could ask additional
questions to elucidate more details.
All interviews were digitally recorded, transcribed,
and analyzed according to Colaizzi’s techniques [10].
Consequently, an inductive system of categories was
developed reflecting the pre-diagnostic phenomena
(experiences, symptoms, and/or observations). Examples of
pre-diagnostic phenomena are given in Table 1. The process
of how the interviews were analyzed to yield a question
is illustrated in Supplemental Table 1 for one category.
Ethical considerations
The ethics committees of Hannover medical university
(Ethikkommission der Medizinischen Hochschule
Hannover, head: Prof. Dr. H.D. Tröger) and Bochum
medical university (Ethik-Kommission der Ruhr Universi-
tät Bochum, head: Prof. Dr. M. Zenz) approved the study.
Table 1 Examples for pre-diagnostic experiences and the process of categorization
Patient experience/citation Category Question
“My husband enjoys hiking, but for me, steep trails were extremely difficult to
manage. I needed to rest often and he would get impatient and cross with
me. But what could I do – there was simply no strength in my legs!”
Gait/gait pattern Can you easily walk uphill?
“Sports in school were simply a nightmare for me. Youth sport meets or any
competitive sport exasperated me. Especially those activities that required
quick movements were a major fail for me”
Sport activities and training When you were young were you able
to keep up in sports?
“During military service we were forced to pass a fitness course. In addition to
other challenges, we had to climb over a six-foot wall. Lifting my body over
the barrier was impossible. So I waited until the sergeant was not looking and I
would instead run around the barricade.”
Conscious or unconscious
compensation of disability
Did you have to “cheat” such as using
alternative muscles when performing
certain activities?
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All patients gave informed consent for the interviews
and all individuals answering the questionnaire gave
their informed consent to participate.
Systematic analysis of the interviews and creation of a
questionnaire
Two researchers (US and LG) reviewed and analyzed the
interviews. Utilizing techniques described by Colaizzi,
patients’ observations were then systematically catego-
rized. A stepwise qualitative analysis was undertaken, in-
cluding extraction of significant phrases, reduction of
the phrases into their essential structures, generation of
a question from the essential structure, and validation of
questions by the interviewees. To organize the observa-
tions and create a questionnaire that would reflect the
important experiences, we classified the content of the
interviews into different categories. Additionally, we in-
corporated an additional step, not part of the Colaizzi’s
stepwise analysis, and created a question reflecting the
pre-diagnostic experiences (Additional file 1). Based on
these categories questions were generated resulting in a
questionnaire that reflected all categories. Likewise, the
questionnaire reflected all the pre-diagnostic phenomena
of the interviewees. In close dialogue with patient sup-
port groups, the maximum length of the questionnaire
was to have no more than two pages and be able to be
completed in less than ten minutes. The answers in the
questionnaire were scaled from 1 (“absolutely not true”)
to 6 (“completely true”). All interviewees as well as pa-
tients who were not interviewed evaluated the questions
and made suggestions to improve the comprehensibility
of the final version of the questionnaire which consisted
of 46 questions. Five questions from the questionnaire
are shown in Table 2 and the complete questionnaire is
provided in the appendix.
Collection of answered questionnaires
After formulating of the questionnaire, patients with an
established diagnosis (based on standard criteria) of the
selected neuromuscular diseases, i.e. muscular dystrophy
and myotonia (MdMy) [including patients with Duchenne
and Becker muscular dystrophy, oculopharyngeal muscu-
lar dystrophy (OPMD), proximal myotonic myopathy
(PROMM), facioscapulohumeral MD, limb-girdle-MD,
myotonia congenita Thomsen], MP, spinal muscular atro-
phy (SMA), ALS, polyneuropathy (PNP), and other neuro-
muscular diseases [including patients with chronic
progressive external opthalmoplegia (CPEO)-plus, poly-
myositis, Ullrich congenital muscular dystrophy, Miyoshi
myopathy, Friedreich ataxia, primary lateral sclerosis
(PLS), and spinal and bulbar muscular atrophy (SBMA)]
were invited (between March 2013 until November 2013)
to complete the questionnaire through our neurological
outpatient clinic or via local patient group sites. To facili-
tate participation, a web-based platform was created to
answer the questionnaire. Individuals without neuromus-
cular disease are interpreted as a 7th disease group.
During this first period, 210 completed questionnaires
were collected and used for cross-validation and later
as a training set to predict the correct diagnosis for
64 new patients in a second step.
Prospective study and extension of the system
The second step, a prospective and multicenter study
with different neurological clinics was initiated between
October 2013 and October 2014. 64 patients with an
established diagnosis of MdMy, MP, SMA, ALS, or PNP
completed the questionnaire. The questionnaires were an-
swered and collected in different hospitals in Hannover
and Bochum, Germany. Only patients with McA disease
were contacted via patient groups.
Data mining techniques
Finding the right diagnosis based on the answer patterns
in the questionnaires can be seen multiclass classifica-
tion problem. The target attribute was the diagnosis and
the elements used for the prediction were the answers to
the questions which are given on an ordinal scale. Most
classifiers are designed to handle either numerical or
categorical attributes. Therefore, the ordinal scale was
interpreted as a numerical scale.
Classifiers are based on different assumptions of how
the classes – the diagnoses – can be identified or sepa-
rated. For instance, linear discriminant analysis is based
on the assumption that each class is represented by a
multivariate normal distribution whereas a decision tree
assumes that the classes can be separated by axes-
parallel hyper-planes. None of these assumptions really
fits the questionnaire data set. Therefore, no single clas-
sifier was chosen but rather an ensemble of classifiers.
Classifier ensembles [32] (i.e. combinations of different
classification algorithms) often lead to better predic-
tions. The application of classifier ensembles in the con-
text of support for medical diagnosis has been described
Table 2 Example of questions used for diagnosing selected
neuromuscular diseases
Q
1 Were you ever diagnosed with an elevated CK level (creatinkinase, a
muscle enzyme)?
2 Have your liver parameter/enzymes ever been elevated without
apparent reason?
3 Is it particularly challenging to walk uphill?
4 Do you have difficulties standing up from a crouch?
5 Do you often stumble when you walk or do your feet feel “sticky”?
Do people describe your walk as “funny” or “particular”?
Q question
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previously [9]. In the current study, however, we used a
combination of eight distinct classifiers (support vector
machine, artificial neural network, fuzzy rule-based, ran-
dom forest, logistic regression, linear discriminant ana-
lysis, naive Bayes, and nearest neighbor) to enhance the
accuracy of the diagnosis. Selecting the six classifiers is
based on the authors’ experience gathered by medical data
evaluation for many years.
Although various classifiers are available, there are main
groups with a similar underlying mathematical concept.
The selected classifiers implement different mathematical
assumptions and a diversity of algorithm structures.
In a first step the evaluation of a single questionnaire
was performed by six different classifier algorithms. For a
patient showing specific symptoms with respect to one of
the seven diagnoses, a majority of the 6 classifiers returned
an identical result. The classifier results are a vector of
probability values for each of the seven diagnoses.
For most questionnaires a fusion algorithm was neces-
sary to perform a weighted majority voting. Each classifier
delivered a disease number as well as a corresponding
probability value for each assumed diagnosis. The max-
imum total sum of all probability values for each single
diagnosis indicated the diagnosis with the highest relative
probability. Summing the probabilities of all classifiers for
each diagnosis yielded a score. The diagnosis with the
highest score was chosen if it exceeded a certain value.
With the probability p(d,c) for the diagnosis d calculated
by the classifier c (c = 1,…6) the diagnosis of the fusion
classifier is given by:argmaxd
X6
c¼1
p d; cð Þ
( )
Evaluation of the classifier ensemble was based on a
21-fold stratified cross-validation algorithm and on case
studies with patients who entered the hospital without
knowing the final diagnoses. The models were developed
and tested by Java software sources including function
calls to the R statistics software package libraries.
Results
Selection of important pre-diagnostic experiences from
the interviews
Many patients experienced a long pre-diagnostic time,
especially those with MP and some with MDs. In the in-
terviews, pre-diagnostic experiences were collected and
categorized (Table 1). Among various narratives belong-
ing to same category, the questions were created to gen-
erate a questionnaire consisting of 46 items reflecting all
categories (Table 1 and Additional file 1).
Creation of a novel questionnaire
The six most important questions in this study are
displayed in Table 1 (the complete questionnaire is available
as Additional file 2).
Building a database and the training period
In total, 274 individuals (210 individuals for the training
data set, 64 new data sets with a diagnosis of MdMy,
ALS, MP, PNP, or SMA) completed the questionnaire.
The return rate of the questionnaire differed between
the diagnostic groups (Table 2). Most questionnaires
were answered through the web-based program between
March and May 2013.
During the first study period, 210 answered question-
naires were collected and used for cross-validation. Due
to the limited size of the data set, we deviated from the
standard 10-fold cross-validation and applied 21-fold
cross-validation in order to always have more samples in
the training set. The specific number 21 was chosen
simply because 21 is a divisor of 210. The 21-fold strati-
fied method selects ten patients for each validation step
and repeats this procedure for all 21 groups. Then a
classifier was built based on all 210 patients. Later on
further 64 new patients filled in the questionnaire and
we applied this classifier to these patients, who did not
belong to the training data set of the 210 former
patients.
Diagnostic accuracy of the system
Results of the training set
For validation purposes, the stratified k-fold cross-
validation, a standardized method used in data mining,
was used for k = 21. In the group of 210 individuals,
89.5 % (+/- 10.7 %) or 188/210 questionnaires were
assigned to the correct diagnosis. The misclassification
rate varied between the different classifiers and disease
groups (Table 3). The fusion classifiers provided the best
results. Here, the diagnostic sensitivity for the detection
of MD was 96 and 93 % for MP, but only 69 % for patients
with spinal muscular atrophy. The compiled category
“other” including a variety of different neurological
diseases exhibited the second worst results (81 % correct
diagnoses, Table 4).
In Table 5, a confusion matrix is shown for the results
of the fusion classifier which combines the results of 6
data mining methods. Depending on the number of pa-
tients and the type of disease in each group the positive
predictive value (PPV) and the negative predictive value
(NPV) vary between 0.83 and 1 for the PPV and between
0.97 and 0.99 for the NPV.
To illustrate the variety between different classifying
systems, the results of different data mining methods
during cross-validation was calculated. The results of the
final fusion classifier were better than the results of sin-
gle classifiers in most of the layers, indicating that the
combination of different classifiers outperforms any sin-
gle classifier in this setting.
The amount of questions gathered by the Colaizzi
method guarantees high sensitivity values reached by the
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data mining algorithms. In test evaluations a stepwise re-
duction of the number questions was investigated with
the result that the sensitivity rates decline with the
number of omitted questions. However, the rate of the de-
cline depends on the impact of a single question on the
sensitivity values measured by ROC/AUC (area under the
curve) values and p-value computations.
Question 40 (“Is it true that physical activities that
you used to be able to do are not possible anymore?”)
serves as an example for a “weaker” question. For
diagnosis 1, question 40 shows a weak p-value for the
corresponding coefficient in logistic regression. If this
question is skipped, the sensitivity value for this diagnosis
declines from 96 % down to 92 %, while the averaged
sensitivity value for all diagnoses performs with only
1 % decrease. Cancelling “weak” questions with less signifi-
cant p-values leads to a moderate decrease in the total sen-
sitivity values, but triggers strong reduction of sensitivity
for single diagnoses. Therefore, the evaluations are
based on the full amount of 46 questions collected by
the Colaizzi method.
The p-values for the questions and the seven diagnoses
under investigation are shown in the Additional file 3.
Results of the prospective trial
During the one-year prospective trial, 64 patients with a
diagnosis of MdMy, MP, SMA, ALS, or PNP answered
the questionnaire (Table 6). In this group, 89 % correct
diagnoses were provided. The distribution in the differ-
ent disease groups varied. Especially in patients with
PNP, there was a relevant rate of incorrect diagnoses.
Results in patients without a diagnosis at first encounter
Nine individuals were included into the trial, who did
not have a definitive diagnosis at the time of completion
of the questionnaire. They were referred to a tertiary
center to establish a final diagnosis based on sympto-
mology. There was suspicion for a neuromuscular dis-
ease by the referring neurologist, but the diagnosis
needed confirmation at a tertiary clinic. Two out of four
patients, later confirmed to have PNP, received the cor-
rect diagnosis employing the computer program. The
Table 4 Sensitivity (%) of different classifiers in selected neuromuscular disease groups during 21-fold cross-validation
Diagnostic group Classifier system MdMya (1) MP (2) SMA (3) ALS (4) PNP (5) Otherb (6) NNDc (7)
SVM 92 84 38 78 77 56 89
RF 100 93 69 93 73 63 97
LR 84 86 56 81 73 81 94
NB 94 88 56 52 73 75 92
LD 94 88 69 81 77 81 94
NN 76 81 44 52 64 50 94
Fusion 96 93 69 81 86 81 97
SVM support vector machine, RF random forest, LR logistic regression, NB naive Bayes, LD linear discriminant analysis, NN nearest neighbor
aincluding patients with Duchenne and Becker muscular dystrophy (MD), oculopharyngeal muscular dystrophy (OPMD), proximal myotonic myopathy (PROMM),
facioscapulohumeral MD, progressive MD, limb-girdle-MD, myotonia congenita Thomsen
bincluding patients with chronic progressive external opthalmoplegia (CPEO) -plus, polymyositis, Lambert-Eaton myasthenic syndrome, Ullrich congenital muscular
dystrophy, Miyoshi myopathy, Friedreich ataxia, primary lateral sclerosis (PLS), spinal and bulbar muscular atrophy (SBMA), and chronic inflammatory demyelinating
polyneuropathy (CIDP)
cNND no neuromuscular disease
Table 3 Study population (training data set, n = 210; prospective data of known diagnoses, n = 64)






Diagnosis 1 (muscular dystrophy/myotonia, MdMy)a 50 10 60
Diagnosis 2 (Pompe disease, MP) 43 2 45
Diagnosis 3 (spinal muscular atrophy, SMA) 16 4 20
Diagnosis 4 (amyotrophic lateral sclerosis, ALS) 27 17 44
Diagnosis 5 (polyneuropathy, PNP) 22 23 45
Diagnosis 6 (other neuromuscular diseases, OND)b 16 8 24
Diagnosis 7 (no neuromuscular disease, NND) 36 0 36
Total 210 64 274
aIncluding patients with Duchenne and Becker muscular dystrophy (MD), oculopharyngeal muscular dystrophy (OPMD), proximal myotonic myopathy (PROMM),
facioscapulohumeral MD, progressive MD, limb-girdle-MD, myotonia congenita Thomsen
bIncluding patients with chronic progressive external opthalmoplegia (CPEO)-plus, polymyositis, Ullrich congenital muscular dystrophy, Miyoshi myopathy,
Friedreich ataxia, primary lateral sclerosis (PLS), spinal and bulbar muscular atrophy (SBMA)
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remaining two PNP patients were incorrectly classified
as SMA. One patient subsequently diagnosed with ALS,
was correctly diagnosed by our system. Four patients
with diagnoses unknown to the system (vasculitis, MG,
rhabdomyolysis, and polymyositis) were correctly classi-
fied as “other neuromuscular diseases”.
Results of the ROC curves, AUC values, confusion matrix
and p-values
Receiver operating characteristic (ROC) curves and the
area under the ROC curve (AUC) were also used to
evaluate the predictive power of our approach. Finally, a
validation of the importance of the questions was carried
out. On the one hand, a p-value for each question was
calculated based on the significance (deviation from zero)
of the corresponding coefficient in logistic regression
(Additional file 3). On the other hand, the performance of
the system was tested by leaving out questions with less
significant p-values.
Figure 1 illustrates the high diagnostic accuracy of
different classifiers with the best results for the fusion
classifier for individuals with Pompe disease.
Discussion
The main findings of this study are that patients with
selected neuromuscular diseases could be identified or
distinguished using data mining in conjunction with
answer pattern analysis from newly developed question-
naire. Secondly, the results of the study support the notion
that data mining methods show plasticity and expandabil-
ity, making this approach a promising tool for modern
diagnostics. Indeed, the diagnostic accuracy of the tool
was nearly 90 % depending on the diagnostic group. Good
results for NPV and PPV could be reached but need con-
firmation in a larger scale study. These preliminary results
support our hypothesis that medical history taking, which
Table 5 The fusion classifier exhibits good PPV and NPV based on 21-fold cross-validation
MdMy (n = 50) MP (n = 43) SMA (n = 16) ALS (n = 27) PNP (n = 22) other (n = 16) NND (n = 36)
48 3 3 1 0 1 0
2 40 0 0 0 0 0
0 0 11 0 1 1 0
0 0 0 22 2 0 0
0 0 1 1 19 1 1
0 0 0 0 0 13 0
0 0 1 3 0 0 35
PPV 0.87 0.95 0.85 0.92 0.83 1 0.90
NPV 0.98 0.98 0.97 0.97 0.98 0.98 0.99
Table 6 Diagnostic results during the prospective trial in 64
patients
MdMy MP SMA ALS PNP other no
MdMy 10 1 0 0 1 1 0
MP 0 1 0 0 0 0 0
SMA 0 0 4 0 2 0 0
ALS 0 0 0 17 0 0 0
PNP 0 0 0 0 18 0 0
other 0 0 0 0 2 7 0
no 0 0 0 0 0 0 0
total 10 2 4 17 23 8 0
MdMy muscular dystrophy, MP Pompe Disease, SMA spinal muscular atrophy,
ALS amyotrophic lateral sclerosis, PNP polyneuropathy; other see Table 2
Fig. 1 ROC curves and AUC values indicate variable diagnostic
sensitivity among different classifier systems for identifying patients
with Pompe disease. The results are based on the training set of 210
questionnaires during cross validation. The best classifier results were
obtained with the fusion classifier (black line, 100 % correct diagnoses),
which identified all 43 Pompe patients during the 21-fold stratified
cross-validation runs
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was simulated here using selected questions, together with
modern computational methods is powerful to assist the
physician in generating a diagnosis.
Diagnostic support is needed for neuromuscular dis-
eases due to a lack of experience with these disease en-
tities by GPs and even many sub-specialties. Often the
diagnosis is delayed. A recent report on patients with
oculopharyngeal muscular dystrophy by Scotland et al.
demonstrated a prolonged time frame, up to 20 years,
before the diagnosis was made [2]. The reasons for the
delay were multiple including patient denial, nonspecific
symptoms, clinical variability, and rarity of the disease
[13–16]. However, the role of the GP as gatekeeper must
be highlighted as well [1, 11, 12]. New systems to remind
medical gatekeepers of rare diseases are highly desirable
and multiple reports addressing delays in diagnosis in
different disease groups underscored this issue [6, 7, 11].
Computer aided diagnostic support dates back to the
1980s [17]. Using databases and statistical algorithms,
scientists attempted to reduce diagnostic mistakes and
enhance diagnostic accuracy [18–21]. Despite some suc-
cess, daily real life application was limited and most
diagnoses are still made by the practitioner without the
assistance of computerized programs. In addition, these
initial computer based diagnostic tools had drawbacks.
First, the programming of rules to update any expert
system is time-consuming and the number of rules to be
incorporated in such a system rises exponentially such
that data entry is often impracticable [22]. Moreover,
self-assessment by doctors has the potential to inadvert-
ently reinforce false concepts to the detriment of excluding
other plausible ideas [23–27]. These barriers were success-
fully addressed in our project by utilizing self-learning data
mining methods and transferring the data entry to patients
who simply answer the questionnaire while waiting to see
the doctor. This structure also takes advantage of the pa-
tient as being an expert on his/her own health.
Unfortunately, the clues for diagnosis are often lost in
the physician-patient communication or the physician
simply do not appreciate the patient’s perspective fully
[28, 29]. Exploring the past medical history thoroughly is
a cornerstone of the medical evaluation, but it is ham-
pered by lack of time and misunderstanding between
health professionals and patients [30, 31]. On the other
hand, patients with rare chronic diseases are experts in
detecting the signs and symptoms of their disease.
Careful attention to patients’ experiences as related to
their disease gives important hints for additional work up.
These ideas were successfully integrated into our diagnos-
tic support tool using questions developed from patients’
pre-diagnostic experiences [29].
The diagnostic delay in patients with neuromuscular
disorders is influenced by the treating physician at first
encounter [2]. A neurologist might not need a diagnostic
support tool for detecting neuromuscular diseases, but
for a GP this could be different. The patient with certain
key symptoms (e.g. fatigue, cramps, muscle twitching/
fasciculations, tripping, slurred speech, or muscle weak-
ness) could answer the questionnaire in the waiting
room. The putative diagnosis would be immediately dis-
played to the physician who could then consider the
suggested diagnosis and explore the past medical history
in more detail to help refute or substantiate the diagno-
sis and request additional laboratory or radiological
exams prior to referring the patient to a subspecialist.
Our study has certain limitations, however. First, we
conducted interviews and collected questionnaires on a
heterogeneous group of individuals and the number was
small. This might have resulted in a selection bias of the
final questions. Importantly, some observations are not
reflected in the current questionnaire. Although this
may reflect the daily work of a GP who cannot ask all
possible questions, it also reveals the restraints of a
questionnaire-based diagnostic tool. Second, the tool
under investigation does not render a definitive diagno-
sis but rather directs the GP to a diagnostic group. The
treating physician can prompt further testing to reach a
definite diagnosis. Of note, we choose only six neuro-
muscular diseases where diagnostic delay is common,
but many other conditions with similar symptoms can-
not be diagnosed with this tool at the current time. In
addition, one might criticize the system for overfitting
and as such being biased for detecting certain diseases
much better than detecting a simple muscle ache.
However, this may be partially remedied by prospective
testing and expansion of the system with new diagnoses
(e.g. McA, MMN, and IBM). However, the pilot evaluation
of nine patients without a diagnosis resulted in high qual-
ity diagnostic suggestions. Third, the prospective trial in-
cluded only patients with an established neuromuscular
disease but no other diagnoses, e.g. chronic cardiac or pul-
monary diseases, mimicking a neuromuscular disorder.
The training data set of 210 questions as well as the
prospective tests with 64 patients was relatively small
and did not represent all possible disease manifestations
or all possible neuromuscular diseases. Particularly in
the group of patients with muscular dystrophies, we col-
lected questionnaires from patients with different diag-
noses who were then computed into one larger group,
resulting in more heterogeneity in the group. The next
challenge for the system will be to detect individuals
with fibromyalgia and pulmonological or psychosomatic
disorders, which will be addressed in a future trial. How-
ever, as a surprising proof of concept, our data showed
that it is possible to generate a diagnostic hint of neuro-
muscular diseases by computer-based analysis of answer
patterns. In contrast, internet search engines of symp-
toms for self-diagnosis showed disappointing results for
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motor neuron diseases [33]. The application of data
mining techniques improved the diagnostic quality in se-
lected clinical scenarios [34]. Recently, the combination
of questionnaires and data mining techniques proved
very successful for diagnosing rare pulmonary diseases
in children [35]. A randomized study performed by
Kostopoulou and co-workers recently demonstrated
the beneficial effects of computerized support on the diag-
nostic accuracy of GPs indicating the potential value of
CDSS for clinical usage [36]. A similar study is planned
with the tool under investigation here to analyze its bene-
fit for the clinical use.
Conclusions
In conclusion, these preliminary data indicate that in-
dividuals with selected neuromuscular diseases share
symptoms and experiences in the pre-diagnostic
period which were exploited to develop a specific
questionnaire and subsequent data mining techniques
of answer patterns. A diagnostic support tool may
help the GP to identify patients with unspecific symptoms
that might be the first indication of a rare neuromuscular
disease. Today this tool covers only limited diseases and
diagnostic categories. Therefor this system is not yet ready
for the clinical use. Further trials are needed before this
system may be integrated into routine clinical use.
Additional files
Additional file 1: Test data set of the study. (DOCX 16.2 kb)
Additional file 2: Training data set of the study. (DOC 26.5 kb)
Additional file 3: P-value calculations for questions in different disease
groups. (TIF 1.80 mb)
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